CLN6-related neuronal ceroid lipofuscinosis (NCL6) is an inherited disease that causes degeneration of the brain, leading to a progressive loss of mental and motor skills.
There are several forms of NCL, largely differentiated by the gene responsible and the age at which symptoms begin. Mutations in the CLN6 gene typically result in variant late-infantile neuronal ceroid-lipofuscinosis (vLINCL) or rarely, adult-onset NCL (Kufs disease type A).
Variant late-infantile neuronal ceroid-lipofuscinosis The symptoms of vLINCL typically begin between 3 and 8 years of age. Early symptoms often include seizures, vision loss and difficulty controlling movements. Other symptoms include jerking movements, mental decline, and speech problems. In general, most children with vLINCL will lose all motor skills and vision by 4-10 years of age. Death occurs around 20 years of age.
Adult-onset NCL The symptoms of adult-onset NCL typically begin around the age of 30 but range between 16-51 years. Individuals experience difficulty controling seizures, dementia and have difficulty balancing and controlling movements. Death usually occurs 10 years after the onset of symptoms. Vision is not affected in adult-onset NCL.
Approximately 1 in 25,000 people globally are affected by some form of NCL. The exact incidence and prevalence of CLN6-related neuronal ceroid lipofuscinosis is unknown.
There is no cure for CLN6-related neuronal ceroid lipofuscinosis. Symptoms such as seizures and poor muscle tone can be treated as they arise with various medications. Some individuals may benefit from a feeding tube.
The prognosis for people with the disease is poor. Individuals with variant late-infantile neuronal ceroid-lipofuscinosis generally lose their vision and all motor skills by 4 to 10 years of age. Lifespan is around 20 years of age. Individuals with adult-onset NCL generally pass within 10 years of the onset of symptoms.
An international support and research networking organization for families of children and young adults with Batten disease (JNCL).
Phone: (800) 448-4570
A medical database of genetic disorders funded by the National Institutes of Health and developed at the University of Washington, Seattle. Much of the language in GeneReviews is meant for physicians and other scientists. This webpage also discusses numerous forms of neuronal ceroid lipofuscinosis. Direct your attention to CLN5.
An organization that supports individuals and their families living with lysosomal disease. It also helps find treatment for and supports research on various forms of lysosomal disease.
Phone: (888) 858-7894
An online fact sheet on Batten disease published by NINDS, a division of the National Institutes of Health.
Counsyl has renamed its products effective July 19, 2017. The Family Prep Screen is now the Foresight Carrier Screen.
The new names now appear on all communications from Counsyl. If you have any questions, please contact Counsyl directly.